Group 1 - The core point of the article is that Tongrentang Medical Investment Co., Ltd. has submitted its third listing application to the Hong Kong Stock Exchange, with CITIC Securities as the sole sponsor. If successful, it will become the fourth listed platform under the Tongrentang Group [1] Group 2 - Tongrentang Medical is a traditional Chinese medicine healthcare group providing comprehensive medical services to individual clients and standardized management services to institutional clients, along with various pharmaceutical and other products [5] - As of the latest feasible date, Tongrentang Medical has established a tiered medical service network, including 12 self-owned offline medical institutions and one internet hospital, as well as 10 offline managed medical institutions [5] - By 2024, Tongrentang Medical is the largest non-public traditional Chinese medicine hospital group in China, holding a market share of 1.7% in terms of total outpatient and inpatient visits [5] - In terms of total medical service revenue for 2024, Tongrentang Medical accounts for 46.5% of the total market size of the traditional Chinese medicine healthcare service industry in China [5] - The company's revenue primarily comes from medical services, management services, and sales of health products and other products, with medical services generating approximately 995 million yuan, management services about 9.6 million yuan, and health product sales around 138 million yuan for the fiscal year 2023 [5] - The company's revenue for the fiscal years 2022, 2023, and 2024 was approximately 911 million yuan, 1.153 billion yuan, and 1.175 billion yuan respectively, with net profits of -9.233 million yuan, 42.634 million yuan, and 46.197 million yuan during the same periods [5]

Core Viewpoint - Tongrentang Health Investment Co., Ltd. has submitted a listing application to the Hong Kong Stock Exchange, aiming to leverage its established brand and extensive healthcare network to become a leading health and wellness industry group in China [1][2]. Group 1: Company Overview - Tongrentang Health Investment was established in 2015 and is a secondary group under the Tongrentang Group, which has three listed companies: Tongrentang in A-shares, Tongrentang Technology, and Tongrentang Guoyao in Hong Kong [1]. - The company focuses on the health and wellness sector, utilizing the historical "Tongrentang" brand and a solid industrial foundation to provide modern, customized, and one-stop traditional Chinese medicine services [1]. Group 2: Revenue Structure - The majority of Tongrentang Health's revenue comes from Beijing Tongrentang Traditional Chinese Medicine Hospital and Sanxi Hall Health Hospital, contributing 70.1%, 59.5%, and 65.1% of total revenue from 2021 to 2023 [2]. - Medical service revenue accounts for over 80% of the company's total revenue, with figures of 450 million, 596 million, and 731 million yuan from 2021 to 2023, representing 95.8%, 85.5%, and 81.6% of total revenue respectively [2]. Group 3: Financial Performance - The company's revenue increased from 470 million yuan in 2021 to 895 million yuan in 2023, with a compound annual growth rate (CAGR) of 38% [3]. - Gross profit rose significantly from 79.22 million yuan in 2021 to 193 million yuan in 2023, achieving a CAGR of 56.2% [3]. - After two years of losses, the company reported a profit of 44.59 million yuan in 2023 [3].

Group 1 - The core viewpoint of the news is that Beijing Tongrentang Medical Investment Co., Ltd. has submitted a listing application to the Hong Kong Stock Exchange, with CITIC Securities as the sole sponsor [1] - The company is a traditional Chinese medicine (TCM) healthcare group that provides comprehensive TCM medical services to individual clients and standardized management services to institutional clients [4] - As of June 24, 2025, the company has established a tiered medical service network, including 12 self-owned offline medical institutions and one internet hospital, along with 10 offline managed medical institutions [4] Group 2 - The company is the largest TCM hospital group in China's non-public hospital sector, with a market share of 1.7% based on total outpatient and inpatient visits in 2024 [4] - The company ranks second in the non-public TCM hospital sector with a market share of 0.2% based on total medical service revenue in 2024, capturing 46.5% of the total market size of China's TCM medical services [4] - Revenue sources for the company include medical services, management services, and sales of health products, with medical services generating approximately 995 million RMB, management services about 9.6 million RMB, and health product sales around 138 million RMB for the fiscal year 2023 [4] Group 3 - The company's revenue for the fiscal years 2022, 2023, and 2024 was approximately 911 million RMB, 1.15 billion RMB, and 1.18 billion RMB, respectively, with net profits of -9.23 million RMB, 42.63 million RMB, and 46.2 million RMB during the same periods [6][7] - The gross profit for the same years was approximately 142.77 million RMB, 217.48 million RMB, and 222.5 million RMB, indicating a steady increase in profitability [7]

据港交所文件：北京同仁堂医养投资股份有限公司向港交所提交上市申请书。 相关链接 ...

北京同仁堂医养投资股份有限公司向港交所提交上市申请书，独家保荐人为中金公司（601995）。 ...

Core Viewpoint - The establishment of the "Party Building Leading Industry Innovation Joint Mechanism" by three state-owned enterprises in Beijing aims to integrate party building with business operations, enhancing innovation and collaboration in traditional industries [1][3][8]. Group 1: Mechanism Establishment and Development - The "Party Building Leading Industry Innovation Joint Mechanism" was initiated by Tongrentang Group, Shoulu Group, and Jingneng Group, and has expanded from 3 to 15 member units within a year [3][11]. - The mechanism focuses on enhancing enterprise efficiency, competitiveness, and the preservation and appreciation of state-owned assets through party building [3][15]. Group 2: Achievements and Innovations - Over 60 collaborative projects have been implemented, with a total cooperation amount nearing 27 million yuan, demonstrating the effective integration of party building and business operations [4][7]. - The mechanism has successfully launched joint products that combine traditional culture with modern consumption, such as "Mid-Axis Food Gifts" and "Nourishing Tea" [7][9]. Group 3: Community Engagement and Social Responsibility - A series of community service events, including a "Beneficial Market," showcased products from member units, enhancing public interaction and promoting health and wellness [9][10]. - The distribution of the "Elderly Care Service Manual" and health education initiatives reflect the commitment of state-owned enterprises to social responsibility and community welfare [10][11]. Group 4: Future Prospects and Strategic Goals - The mechanism is seen as a model for integrating party building with business practices, providing a replicable framework for state-owned enterprises nationwide [11][16]. - The ongoing collaboration among diverse sectors, including education and technology, aims to foster innovation and resource sharing, contributing to the high-quality development of the capital [14][15].

Core Viewpoint - The article outlines the management system for fund transactions between Beijing Tongrentang Co., Ltd. and its controlling shareholders, actual controllers, and other related parties, aiming to prevent fund occupation and protect investors' rights [1][2]. Group 1: Regulations on Fund Transactions - The company establishes a system to regulate fund transactions with controlling shareholders and related parties to prevent fund occupation and ensure compliance with legal requirements [1][2]. - All fund transactions between the company and its controlling shareholders, actual controllers, and related parties are subject to this system [1][2]. - The controlling shareholders and actual controllers have a duty of good faith towards the company and its public shareholders, and must not harm their interests through various means [1][2]. Group 2: Prohibited Actions - The controlling shareholders and related parties are prohibited from occupying company funds in any form, including through temporary occupation or small amounts in multiple batches [3]. - The company must not provide funds directly or indirectly to controlling shareholders or related parties for various expenses or loans without proper justification [2][3]. - Any transactions with controlling shareholders must comply with the company's decision-making procedures and information disclosure obligations [3][4]. Group 3: Financial Oversight and Accountability - The company's financial department must strictly adhere to relevant regulations when handling payments related to controlling shareholders and related parties [4]. - The registered accountants must provide a special report on any fund occupation by controlling shareholders during the annual audit [4]. - The company must conduct self-inspections regarding fund transactions and take corrective actions if any violations are found [4][5]. Group 4: Asset Settlement and Compliance - Funds occupied by controlling shareholders should generally be repaid in cash, with strict controls on non-cash asset settlements [5]. - Any non-cash assets used for repayment must meet specific criteria and undergo evaluation by qualified intermediaries [5]. - The company must ensure that any asset settlement proposals are approved by the shareholders' meeting, with related party shareholders abstaining from voting [5][6]. Group 5: Legal and Regulatory Compliance - If controlling shareholders have occupied company funds or engaged in illegal guarantees before transferring control, they must return the funds and resolve any violations [6]. - Violations of this system by the company or its executives may result in administrative penalties or criminal liability [6]. - The system will be revised as necessary to comply with future legal changes, and the board of directors is responsible for its interpretation [6].

北京同仁堂股份有限公司 累积投票制实施细则 第一章 总 则 第一条 为进一步完善北京同仁堂股份有限公司（以下简称公司）法人 治理制度，维护中小股东的合法权益，根据《中华人民共和国公司法》《中华 人民共和国证券法》 《上市公司治理准则》 《上海证券交易所股票上市规则》 （以 下简称《上市规则》）、上海证券交易所上市公司自律监管指引、《北京同仁堂 股份有限公司章程》 （以下简称《公司章程》）及其他有关法律、法规、规范性 文件之规定，制定本细则。 第二条 本细则所称的累积投票制是指股东会选举董事时，每一股份拥 有与应选董事人数相同的表决权，股东拥有的表决权可以集中使用。董事会应 当向股东公告候选董事的简历和基本情况。 第三条 董事的选举，应当充分反映中小股东意见。股东会就选举董事 进行表决时，应当采取累积投票制。 第四条 本细则所称董事包括非独立董事和独立董事，职工民主选举的 职工代表董事不适用于本细则的相关规定。 第二章 累积投票制的投票原则 第五条 当符合任职资格的候选人多于应选人数时，实行差额选举。 第六条 股东会对董事候选人进行表决前，股东会主持人应明确告知与 会股东实行累积投票方式选举董事，公司须制备适合 ...

Core Points - The document outlines the external investment management measures of Beijing Tongrentang Co., Ltd. to regulate investment activities, enhance legal benefits, and reduce risks [1] - The external investment refers to the company's activities aimed at obtaining future returns through monetary funds, equity, and other legally permissible assets [1] - The management structure for external investments includes the shareholders' meeting as the highest decision-making body, with the board of directors and management responsible for investment decisions [2][3] Chapter Summaries Chapter 1: General Principles - The purpose of the external investment management measures is to ensure compliance with laws and regulations, align with national industrial policies, and enhance the company's core competitiveness [1] - The measures apply to the company and its subsidiaries [1] Chapter 2: Organizational Management - The shareholders' meeting is the highest decision-making body for external investments, while the board of directors and management handle specific investment decisions [2] - A dedicated external investment management department is established to execute and implement investment projects [2] Chapter 3: Authority and Approval - A strict review and decision-making process is established for external investments, requiring approval from the board of directors and shareholders for major projects [3][4] - Related party transactions must follow additional approval procedures [3] Chapter 4: Investment Management - The investment management process includes five stages: screening, project initiation, review, implementation, and post-investment management [4] - Investment projects must align with national laws and company policies, and a project initiation report must be submitted for approval [5] Chapter 5: Transfer and Recovery of Investments - The company can recover investments under specific circumstances, such as project completion or bankruptcy [7] - Investment transfers are permitted if projects deviate from the company's strategic direction or show continuous losses [8] Chapter 6: Information Disclosure - The company must adhere to legal obligations for information disclosure regarding investment activities [9] - Subsidiaries are required to appoint a liaison for communication with the board regarding investment disclosures [9] Chapter 7: Supplementary Provisions - Any matters not covered by these measures will follow national laws and regulations [9] - The board of directors is responsible for interpreting these measures, which take effect upon approval by the shareholders' meeting [9]

Core Points - The company aims to protect the legal rights of shareholders, employees, and creditors while adhering to various laws and regulations [2][4] - The company was established as a joint-stock company in accordance with the Company Law and has a registered capital of RMB 1,371,470,262 [3][6] - The company emphasizes the importance of the Communist Party's leadership in its governance and operations [5][6] Company Overview - The registered name of the company is Beijing Tong Ren Tang Co., Ltd., with its English name being the same [3] - The company is located in Daxing District, Beijing, with a postal code of 102629 [3] - The company was approved for its initial public offering of 50 million shares in May 1997 [3][4] Governance Structure - The chairman represents the company in executing its affairs and is the legal representative [3][4] - The company has established a party organization that plays a core leadership role, ensuring the integration of party leadership and corporate governance [5][6] - The company’s articles of association serve as a legally binding document for the rights and obligations of shareholders and management [4][5] Business Objectives and Scope - The company's business objective is to uphold the traditional values of Tong Ren Tang while promoting high-quality development in the traditional Chinese medicine industry [6] - The company is engaged in the manufacturing and processing of traditional Chinese medicine, cosmetics, and various other related services [6][7] Share Structure - The company has issued a total of 1,371,470,262 shares, all of which are ordinary shares [7][8] - The issuance of shares follows principles of openness, fairness, and justice, ensuring equal rights for all shareholders [7][8] Shareholder Rights and Responsibilities - Shareholders have the right to receive dividends, participate in shareholder meetings, and supervise the company's operations [14][15] - Shareholders are obligated to comply with laws and regulations and cannot withdraw their capital except as legally permitted [18][19] Shareholder Meetings - The company holds annual shareholder meetings within six months after the end of the fiscal year [55] - Special meetings can be convened under specific circumstances, such as when requested by shareholders holding more than 10% of the shares [56][57] Financial Transactions and Approvals - Major financial transactions, including asset purchases and external investments, require shareholder approval if they exceed specified thresholds [47][48][49] - The company must disclose significant financial guarantees and related transactions to ensure transparency [51][52]